Management of comorbid bipolar disorder and substance use disorders-Reference-Cited by-同舟云学术

Management of comorbid bipolar disorder and substance use disorders

Published:2017-03-16 Issue:4 Volume:43 Page:366-376
ISSN:0095-2990
Container-title:The American Journal of Drug and Alcohol Abuse
language:en
Short-container-title:The American Journal of Drug and Alcohol Abuse

Author:

Salloum Ihsan M.¹^ORCID,Brown Edson Sherwood²

Affiliation:

1. Division of Alcohol and Substance Abuse, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA

2. Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/00952990.2017.1292279

Reference88 articles.

1. Prevalence and Co-occurrence of Substance Use Disorders and IndependentMood and Anxiety Disorders

2. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study

3. Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders

4. Diagnostic and Statistical Manual of Mental Disorders

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuity of psychiatric care among patients with bipolar disorder in the Netherlands;International Journal of Social Psychiatry;2024-09-04

2. Lifetime prevalence of psychiatric comorbidities in patients with bipolar disorder: A systematic review and meta-analysis;Psychiatry Research;2024-07

3. Connections between specific mental health diagnoses of schizophrenia, bipolar disorder and schizoaffective disorder and primary substance use;Advances in Dual Diagnosis;2024-05-16

4. Trastorno afectivo bipolar y trastorno por uso de sustancias. Prevalencia y factores asociados a la patología dual en población general de Colombia;Revista Colombiana de Psiquiatría;2024-04

5. Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study;Pharmacy;2024-02-01